Loading
This study tests TROP-2-directed treatment; the registry reports that it is withdrawn.
The registry lists NCT05060276 as withdrawn, last updated 2023-01-26. Enrolment is 0 actual participants. Interventions: STI-3258. Primary measures include Incidence of adverse events by type, frequency, severity, and causality (safety); Incidence of treatment-emergent adverse events by type, frequency, severity, and causality (safety). The registry reason for stopping is: Protocol changed to Phase 2 No results are posted in the registry; this does not exclude separate publications.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-08. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/